Company news
Mangoceuticals, Inc. news in 2025
Mangoceuticals, Inc.'s news releases, calls and decks from 2025, newest first.
Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements
December 19, 2025
Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy
December 18, 2025
Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules
December 18, 2025
Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs
November 13, 2025
Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management
November 13, 2025
Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu
May 27, 2025
Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division
April 25, 2025
Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions
April 24, 2025
CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape
April 22, 2025
Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada
March 25, 2025
Mangoceuticals Announces the Launch of “PeachesRx” - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments
February 20, 2025
Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution
February 11, 2025
Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research
February 5, 2025
Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation
February 2, 2025